Literature DB >> 30383591

Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy.

Sara Gianella1, Vincent C Marconi2, Baiba Berzins3, Constance A Benson1, Paul Sax4, Carl J Fichtenbaum5, Timothy Wilkin6, Millie Vargas1, Qianqian Deng1, Michelli F Oliveira1, Carlee Moser7, Babafemi O Taiwo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30383591      PMCID： PMC6231952          DOI： 10.1097/QAI.0000000000001863

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.771


× No keyword cloud information.
  22 in total

Review 1.  Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.

Authors:  Laura J Else; Stephen Taylor; David J Back; Saye H Khoo
Journal:  Antivir Ther       Date:  2011

2.  Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Authors:  Sara Gianella; Sheldon R Morris; Christy Anderson; Celsa A Spina; Milenka V Vargas; Jason A Young; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

3.  Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance.

Authors:  Claudia F Althaus; Sara Gianella; Philip Rieder; Viktor von Wyl; Roger D Kouyos; Barbara Niederöst; Adrian Schmid; Karin J Metzner; Beda Joos; Huldrych F Günthard; Marek Fischer
Journal:  J Virol Methods       Date:  2010-01-29       Impact factor: 2.014

4.  Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy.

Authors:  P M Sheth; T J Yi; C Kovacs; K S Kemal; R B Jones; B Osborne; R Pilon; C la Porte; M Ostrowski; T Mazzulli; H Burger; B Weiser; R Kaul
Journal:  Mucosal Immunol       Date:  2012-02-08       Impact factor: 7.313

5.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

6.  Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.

Authors:  Anne-Geneviève Marcelin; Roland Tubiana; Sidonie Lambert-Niclot; Gilles Lefebvre; Stéphanie Dominguez; Manuela Bonmarchand; Daniele Vauthier-Brouzes; Françoise Marguet; Nathalie Mousset-Simeon; Gilles Peytavin; Catherine Poirot
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

7.  Semen may harbor HIV despite effective HAART: another piece in the puzzle.

Authors:  Philippe Halfon; Claude Giorgetti; Hacène Khiri; Guillaume Pénaranda; Philippe Terriou; Géraldine Porcu-Buisson; Véronique Chabert-Orsini
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

8.  Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies.

Authors:  Osvaldo Zagordi; Rolf Klein; Martin Däumer; Niko Beerenwinkel
Journal:  Nucleic Acids Res       Date:  2010-07-29       Impact factor: 16.971

Review 9.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

Authors:  Suzanna Attia; Matthias Egger; Monika Müller; Marcel Zwahlen; Nicola Low
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

10.  Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men.

Authors:  Sara Gianella; Davey M Smith; Milenka V Vargas; Susan J Little; Douglas D Richman; Eric S Daar; Michael P Dube; Fan Zhang; Christina C Ginocchio; Richard H Haubrich; Sheldon R Morris
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079
View more
  3 in total

1.  No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial.

Authors:  Jonathan Z Li; Paul E Sax; Vincent C Marconi; Jesse Fajnzylber; Baiba Berzins; Amesika N Nyaku; Carl J Fichtenbaum; Timothy Wilkin; Constance A Benson; Susan L Koletar; Ramon Lorenzo-Redondo; Babafemi O Taiwo
Journal:  Open Forum Infect Dis       Date:  2019-02-11       Impact factor: 3.835

2.  Patient-centered Care and Treatment in HIV Infection.

Authors:  Massimiliano Lanzafame; Sandro Vento
Journal:  EClinicalMedicine       Date:  2019-01-10

3.  Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis.

Authors:  Gilles Wandeler; Marta Buzzi; Nanina Anderegg; Delphine Sculier; Charles Béguelin; Matthias Egger; Alexandra Calmy
Journal:  F1000Res       Date:  2018-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.